跳至主要内容
临床试验/KCT0008801
KCT0008801招募中Unknown

Study on prevention of hypercapnia by carbon dioxide monitoring during sedation for endoscopic submucosal dissection: a randomized controlled trial

Samsung Medical Center0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • ASA class I~III adult
  • ASA I : a normal healthy patient (healthy, non-smoking, no or minimal alcohol use)
  • ASA II : A patient with mild systemic disease (Current smoker, social alcohol drinker, 30<40, well-controlled HTN/DM, mild lung disease)
  • ASA III : A patient with severe systemic disease (Poorly controlled DM or HTN, COPD, morbid obesity, active hepatitis, moderate reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, history of MI, CVA, TIA, or CAD/stents more than 3 months ago)
  • - Undergoing endoscopic submucosal dissection with sedation

排除标准

  • Patients under 18 years of age
  • Patients requiring oxygen therapy
  • Patients unable to breathe through the nose
  • Patients with coagulation disorders or those at risk of nasal bleeding
  • Patients who have experienced or exacerbated Congestive Heart Failure within the past 6 months
  • Patients with increased intracranial pressure
  • Patients classified as ASA class IV or higher
  • Patients with hemodynamically unstable conditions
  • Patients with a history of pneumothorax
  • Patients with infections in the oral or nasal cavities
  • Pregnant or breastfeeding patients
  • Patients who do not understand or refuse to participate in the study
  • Patients with a history of severe psychiatric disorders that may influence patient assessment

研究者

相似试验